Anzeige
Mehr »
Samstag, 07.06.2025 - Börsentäglich über 12.000 News
Der nächste Perpetua? Warum NevGolds neueste Bohrergebnisse den Vergleich mit dem Milliardenwert PPTA nähren
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3CMUC | ISIN: SE0015987946 | Ticker-Symbol: 9480
Frankfurt
06.06.25 | 21:38
0,289 Euro
-0,34 % -0,001
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
SYNTHETICMR AB Chart 1 Jahr
5-Tage-Chart
SYNTHETICMR AB 5-Tage-Chart

Aktuelle News zur SYNTHETICMR Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
SYNTHETICMR Aktie jetzt für 0€ handeln
DiSYNTHETICMR AB: New Multicenter Study Demonstrates SyMRI's Potential to Transform Clinical Neuroimaging Workflows1
20.05.Report from Annual General Meeting in SyntheticMR AB (publ)1
20.05.SYNTHETICMR AB: Interim report January - March 20251
22.04.Notice to attend the annual general meeting of SyntheticMR AB (publ)2
25.02.SYNTHETICMR AB: Year-End report January - December 20249
30.01.SYNTHETICMR AB: SyntheticMR Receives Regulatory Clearance of SyMRI 3D in Japan3
24.01.Spotlight Stock Market: Market Notice 24/25 - Trading halt in SyntheticMR AB's BTA2
21.01.SyntheticMR AB (publ) appoints CFO Johanna Norén as Acting CEO3
17.01.Vedran Beglerbegovic appointed as new CEO of SyntheticMR AB (publ)2
16.01.SYNTHETICMR AB: SyntheticMR announces final outcome in the oversubscribed rights issue3
14.01.SYNTHETICMR AB: SyntheticMR's rights issue oversubscribed - preliminary outcome is announced1
02.01.SYNTHETICMR AB: SyntheticMR completes the acquisition of Combinostics Oy4
20.12.24SYNTHETICMR AB: SyntheticMR publishes disclosure document regarding rights issue2
17.12.24Announcement from extra general meeting in SyntheticMR AB (publ)1
17.12.24XFRA CAPITAL ADJUSTMENT INFORMATION - 17.12.2024227Das Instrument 14B NO0010776990 HUDDLY AS -,000625 EQUITY wird ex Kapitalmassnahme gehandelt am 17.12.2024 The instrument 14B NO0010776990 HUDDLY AS -,000625 EQUITY is traded ex capital adjustment on...
► Artikel lesen
13.12.24Spotlight Stock Market: Market Notice 263/24 - Information regarding the rights issue from SyntheticMR AB1
02.10.24SyntheticMR AB: SyntheticMR Receives Regulatory Approval for SyMRI 15 in Switzerland393LINKÖPING, Sweden, Oct. 2, 2024 /PRNewswire/ -- SyntheticMR AB, global leader in advanced quantitative imaging software, is pleased to announce that its SyMRI 15 solution has received regulatory...
► Artikel lesen
09.09.24XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 09.09.2024930The following instruments on XETRA do have their first trading 09.09.2024 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 09.09.2024 Aktien 1 JP3701000006 JCR Pharmaceuticals...
► Artikel lesen
26.06.24SyntheticMR AB: SyMRI 15 by SyntheticMR obtains CE-Marking582SyntheticMR announced today that version 15 of their next-generation imaging solution, SyMRI Neuro, has obtained CE-marking. LINKÖPING, Sweden, June 26, 2024 /PRNewswire/ -- SyMRI...
► Artikel lesen
19 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1